Alison R Gregro is a prominent inventor based in Mount Juliet, TN (US). She has made significant contributions to the field of neuroscience through her innovative work. With a total of seven patents to her name, her research focuses on the muscarinic acetylcholine receptor and its implications for treating neurological and psychiatric disorders.

Latest Patents

Her latest patents include positive modulators of the muscarinic acetylcholine receptor M4. These compounds, specifically deuterium-labeled 4-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)oxy)piperidines, are substituted with pyrrolo[3,4-b]pyridin-5-one, furo[3,4-b]pyridin-5(7H)-one, or [1,2,4]triazolo[4,3-a]pyrimidin-3(2H)-one. They are recognized as positive allosteric modulators of the muscarinic acetylcholine receptor M(mAChR M) and may have therapeutic applications in addressing disorders linked to muscarinic acetylcholine receptor dysfunction.

Career Highlights

Alison is affiliated with Vanderbilt University, where she continues her research and development in the field. Her work has garnered attention for its potential impact on treatment strategies for various neurological conditions.

Collaborations

Some of her notable coworkers include Darren W Engers and Craig William Lindsley, who contribute to her research endeavors.

Conclusion

Alison R Gregro's innovative work in the field of neuroscience highlights her commitment to advancing medical science through her patents and research. Her contributions are paving the way for new treatment options for neurological and psychiatric disorders.

This text is generated by artificial intelligence and may not be accurate.